| 2016 | Baek MY, Ahn HK, Park KR, Park HS, Kang SM, Park I, Kim YS, Hong J, Sym SJ, Park J, Lee JH, Shin DB, Cho EK. Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer. Korean J Intern Med. 2016 Apr 20. [Epub ahead of print] |
| 2016 | Ahn HK, Hwang IC, Lee JS, Sym SJ, Cho EK, Shin DB. Neutrophil-Lymphocyte Ratio Predicts Survival in Terminal Cancer Patients. J Palliat Med. 2016 Feb 17.Epub ahead of print. |
| 2015 | Hyun SH, Ahn HK, Ahn MJ, Ahn YC, Kim J, Shim YM, Choi JY. Volume-Based Assessment With 18F-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer. AJR Am J Roentgenol. 2015;Sep;205(3):623-628. |
| 2015 | Kim SW, Hwang IC, Ahn HK, Kyung SY, Ahn HY. Medical Manuscript: Serum Total Testosterone as a Prognostic Indicator in Male Patients With Terminal Cancer. Am J Hosp Palliat Care. 2015 Feb 23. Epub ahead of print. |
| 2014 | Ahn HK, Shin JW, Ahn HY, Park CY, Lee NW, Lee JK, Hwang IC. Metabolic components and recurrence in early-stage cervical cancer. Tumour Biol. 2014 Nov 15 Epub ahead of print |
| 2014 | Woo HS, Ahn HK, Lee HY, Park I, Kim YS, Hong J, Sym SJ, Park J, Lee JH, Shin DB, Cho EK. Epidermal growth factor receptor exon 20 mutations in non-small cell lung cancer and resistance to EGFR-tyrosine kinase inhibitors. Investigational New Drugs. 2014 Aug 23 Epub ahead of print. |
| 2014 | Ahn HK, Jung M, Syn SJ, Shin DB, Kang SM, Kyung SY, Park JW, Jeong SH, Cho EK. A Phase II Trial of Cremorphor EL-free Paclitaxel (Genexol-PM) and Gemcitabine in Patients with Advanced Non-small Cell Lung Cancer. Cancer Chemotherapy Pharmacology. 2014 Aug;74(2):277-82. |
| 2014 | Ahn HK, Jung M, Ha SY, Lee JI, Park I, Kim YS, Hong J, Sym SJ, Park J, Shin DB, Lee JH, Cho EK. Clinical significance of Ki-67 and p53 expression in curatively resected non-small cell lung cancer. Tumour Biology. 2014 Jun;35(6):5735-40. |
| 2013 | Ahn HK, Choi JY, Kim KM, Kim H, Choi SH, Park SH, Park JO, Lim HY, Kang WK, Lee J, Park YS. Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours. British Journal of Cancer. 2013 Sep 17; 109(6):1414-9 |
| 2013 | Ahn HK, Kim SJ, Hwang DW, Ko YH, Tang T, Lim ST, Kim WS. Gemcitabine alone and/or containing chemotherapy is efficient in refractory or relapsed NK/T-cell lymphoma. Investigational New Drugs. 2013 Apr;31(2):469-72. |
| 2013 | Ahn HK, Park YH, Lee SJ, Park S, Maeng CH, Park W, Choi DH, Hur SJ, Ahn JS, Im YH. Clinical implication of time to brain metastasis (TTBM) according to breast cancer subtypes. SpringerPlus. 2013 Mar 28;2(1):136. Print 2013 Dec. |
| 2013 | Ahn HK, Choi YL, Han JH, Ahn YC, Kim K, Kim J, Shim YM, Um SW, Kim H, Kwon OJ, Sum JM, Ahn JS, Park K, Ahn MJ. Epidermal growth factor receptor mutation and treatment outcome of mediastinoscopic N2 positive non-small cell lung cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery. Lung Cancer. 2013 Mar; 79(3):300-6. |
| 2013 | Ahn HK, Jeon K, Yoo H, Han B, Lee SJ, Park H, Lee MJ, Ha SY, Han JH, Sun JM, Ahn JS, Ahn MJ, Park K. Successful treatment with crizotinib in mechanically ventilated patients with ALK positive non-small cell lung cancer. Journal of Thoracic Oncology. 2013 Feb;8(2):250-3. |
| 2013 | Lee HY, Ahn HK, Jeong JY, Kwon MJ, Han JH, Sun JM, Ahn JS, Park K, Choi YL, Ahn JM. Favorable clinical outcomes of pemetrexed treatment in anaplastic lymphoma kinase positive non-small cell lung cancer. Lung Cancer. 2013 Jan;79(1):40-5. |
| 2013 | Kim HJ, Ahn HK, Jung CW*, Moon JH, Park CH, Lee KO, Kim SH, Kim YK, Kim HJ, Sohn SK, Kim SH, Lee WS, Kim KH, Mun YC, Kim W Park J, Min WS, Kim HJ, Kim DH. KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement. Annals of Hematology. 2013 Jan; 92(2):163-71. |
| 2012 | Ahn HK, Suh C, Chuang SS, Suzumiya J, Ko YH, Kim SJ, Huh JR, Yoon DH, Oh SY, Kim JS, Lee SI, Park KW, Hsieh PP, Nakamura S, Yoshino T, Ito K, Nagatani T, Oshimi K, Suzuki R, Kim WS. Extranodal natural killer/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis. Annals of Oncology. 2012 Oct;23(10):2703-7. |
| 2012 | Ahn HK, Lee S, Park YH, Sohn JH, Jo JC, Ahn JH, Jung KH, Park S, Cho EY, Lee JI, Park W, Choi DH, Huh SJ, Ahn JS, Kim SB, Im YH. Prediction of outcomes for patients with brain parenchymal metastases from breast cancer(BC): a new BC-specific prognostic model and a nomogram. Neuro-oncology. 2012 Aug;14(8):1105-13. |
| 2012 | Ahn HK, Lee S, Sun JM, Lee J, Park SH, Park JO, Park YS, Kang WK, Lim HY. Sequential Therapy with sunitinib and sorafenib in metastatic hepatocellular carcinoma. Investigational New Drugs. 2012 Aug;30(4):1768-72. |
| 2012 | Ahn HK, Han B, Lee SJ, Lim T, Sun JM, Ahn JS, Ahn MJ, Park K. ALK inhibitor crizotinib combined with intrathecal methotrexate treatment for non-small cell lung cancer with leptomeningeal carcinomatosis. Lung Cancer. 2012 May;76(2):253-4. |
| 2012 | Ahn HK, Jang JH, Kim K, Kim HJ, Kim SH, Jung CW, Kim DH. Monosomal karyotype in acute myeloid leukemia predicts adverse treatment outcome, and associates with high functional multidrug resistance (MDR) activity. American Journal of Hematology. 2012 Jan;87(1):37-41. |
| 2011 | Ahn HK, Jang J, Lee J, Park SH, Park JO, Park YS, Lim HY, Kim KM, Kang WK. P21-activated kinase 4 overexpression in metastatic gastric cancer patients. Translational Oncology. 2011 Dec;4(6):345-9. |
| 2011 | Lee S, Ahn HK, Park YH, Nam DH, Lee JI, Park W, Choi DH, Huh SJ, Park KT, Ahn JS, Im YH. Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations. Breast Cancer Res Treat. 2011 Oct;129(3):809-17. |
| 2011 | Ahn HK, Uhm JE, Lee J, Lim DH, Seo SW, Sung KS, Lee SJ, Lee DJ, Baek KK, Kim WS, Park JO. Analysis of prognostic factors of pediatric-type sarcomas in adult patients. Oncology. 2011 May 23;80(1-2):21-28 |
| 2011 | Chang MH, Ahn HK, Lee J, Jung CK, Choi YL, Park YH, Ahn JS, Park K, Ahn MJ Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitors. Cancer. 2011 Jan 1;117(1):143-51. |
| 2010 | Ahn HK, Kim SJ, Yun J, Yi JH, Kim JH, Won YW, Kim K, Ko YH, Kim WS. Improved treatment outcome of primary mediastinal large B-cell lymphoma after introduction of rituximab in Korean patients. Int J Hematol. 2010 Apr;91(3):456-63. |
| 2009 | Ahn HK, Song HJ, Lee SJ, Yi JH, Kim SA, Lee J, Kim WS. A case of membranous glomerulonephritis associated with apocrine carcinoma. Korean J Med. 2009:77(suppl 2):415-419. [Korean] |
